#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia positive acute lymphocytic leukaemia Myxoid liposarcoma Ornithine transcarbamoylase deficiency Neonatal asphyxia Anal fistula Anal squamous cell carcinoma Pulmonary arterial hypertension Palmar-plantar erythrodysaesthesia syndrome Familial haemophagocytic lymphohistiocytosis Type IIa hyperlipidaemia Still's disease Cognitive disorder Optic ischaemic neuropathy Cerebral amyloid angiopathy Hereditary angioedema More trials…

    Learn about Rare Diseases

    Glycogen storage disease type II – Basic Information Leukoencephalopathy – Basic Information Testicular leiomyosarcoma – Diagnostics Von Willebrand’s disease – Trials in Disease Primary mediastinal large B-cell lymphoma – Basic Information Encephalitis autoimmune – Diagnostics Combined immunodeficiency – Trials in Disease Ewing’s sarcoma metastatic – Trials in Disease Stevens-Johnson syndrome – Life with Disease Piriformis syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Disitamab Vedotin AGA2118 Daratumumab Ep0042 Acetylcholine Chloride Tenofovir Alafenamide Gsk6097608 RPTR-1-201 Alpha1H Enfortumab Vedotin REGN7544 Citalopram Hydrochloride VG801-1 Tafasitamab Ganciclovir Ly3819469 Sodium Cft1946 ALPROSTADIL Tradipitant Fluorescein Sodium More therapies…

    Learn about Your Condition

    Systemic infection Procedural anxiety Congenital myopathy Mesothelioma Papilloma viral infection Bone marrow failure Lung transplant rejection Mucopolysaccharidosis III Delayed graft function Endocrine ophthalmopathy Breast cancer stage III Complex regional pain syndrome Hepatoblastoma Choroidal neovascularisation ROHHAD syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU Croix Rousse-Lyon

CHU Croix Rousse-Lyon

103 Grande Rue De La Croix Rousse, Lyon, 69317, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Budesonide
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Austria Bulgaria Czechia Denmark Finland France +10

  • Study of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Niraparib
    • Niraparib Tosilate Monohydrate
    Belgium France Italy Spain

  • Study on Amikacin for Treating Mycobacterium Xenopi Lung Infection in Patients Using Amikacin and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amikacin
    • Amoxicillin
    • Ethambutol Hydrochloride
    France

  • Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    France

  • Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small intestine adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Fluorouracil
    • Irinotecan Hydrochloride Trihydrate
    France Italy

  • Study Comparing Adalimumab and Mycophenolate Mofetil for Patients with Steroid-Dependent Non-Infectious Uveitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Uveitis
    Investigated Drugs:
    • Adalimumab
    • Fluorescein Sodium
    • Indocyanine Green
    France

  • Study on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Exl01
    • Vancomycin
    France

  • Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

    Recruiting

    3 1
    Investigated Diseases:
    • Hepatic fibrosis
    Investigated Drugs:
    • Efruxifermin
    France Germany Italy Poland Spain

  • Study on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    Investigated Drugs:
    • Binimetinib
    • Cisplatin
    • Durvalumab
    Belgium France

  • Study on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Nirmatrelvir
    • Remdesivir
    France Italy Norway
Previous Page
1 2 3 4 5 6 … 12
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!